
Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowThe chart is not accessible to screen readers. Please switch to the table view to access the data.
From the year 2014 to 2023, the average cost of antidiabetic drugs in Italy increased by almost **** euros, reaching **** euros per DDD (daily defined dose) in 2023. Breaking down this figure by type of antidiabetic drug, the most expensive was degludec/liraglutide insulin, with an average cost of *** euros per DDD.Â
In recent years, the consumption rate of antidiabetics increased in Italy, growing from **** DDD per 1,000 inhabitants per day in 2014 to **** in 2023. Metformin was by far the most used antidiabetic drug in Italy, followed by dulaglutide and lispro insulin.
The prevalence of diabetes varies across Italy. In 2023, southern regions had the highest prevalence, with almost percent. Therefore, the per capita expenditure on antidiabetic drugs was higher in these regions, reaching almost ** euros per capita in 2023, while the national average was roughly **** euros.
Log in or register to access precise data.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Diabetes in Italy
Deaths due to diabetes
Treatments and eHealth solutions
Demographics and risk factors
Global overview
Costs and revenues of antidiabetics
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.